NEW YORK (Reuters Health) – In patients hospitalized for infection, continuing pre-existing statin therapy does not improve outcomes, and discontinuing the therapy does not lead to an inflammatory…
NEW YORK (Reuters Health) – The common practice of routinely testing patients with ischemic stroke for inherited thrombophilias can do more harm than good, according to a new…
NEW YORK (Reuters Health) – About 1% of outpatient endoscopies require a subsequent visit to the emergency room for related complications, but fewer than a quarter of these…
NEW YORK (Reuters Health) – In order to minimize the risk of potential harms, erythropoiesis-stimulating agents (ESAs) in patients undergoing myelosuppressive chemotherapy should be administered at the lowest…
NEW YORK (Reuters Health) – The reported sensitivity of numerous blood-based markers proposed for the early detection of colorectal cancer (CRC) are probably higher than might be expected…
The first annual Mobile Health Expo was held on October 19-21, 2010 in Las Vegas, NV. The conference was attended by leaders in areas including mobile medicine, wireless…
NEW YORK (Reuters Health) – In patients with mixed dyslipidemia, fenofibric acid added to atorvastatin and ezetimibe results in improved lipid and non-lipid levels, according to a report…
NEW YORK (Reuters Health) – Among low-risk patients undergoing elective percutaneous coronary intervention, 1-year outcomes are worse if their antiplatelet response to clopidogrel is low, an Italian team…
NEW YORK (Reuters Health) – The hope of finding a way to quickly measure carboxyhemoglobin levels in suspected carbon monoxide poisoning is still unfulfilled, it seems. The Rad-57…
NEW YORK (Reuters Health) – In patients being treated for acute coronary syndromes (ACS), the loading dose of ticagrelor has a stronger inhibitory effect on platelets than does…